Vigabatrin side effects
On this page
Form matters for each dose. The ready-to-use liquid needs no mixing; powder is mixed before every dose. In one small study funded by the liquid’s maker, doses made from the liquid were more accurate. Compare the forms
Short answer: in babies, the most common side effects of vigabatrin are sleepiness and irritability, and some babies show changes on brain MRI scans that usually go away when the medicine is stopped. In adults, drowsiness, dizziness, headache and fatigue are the most common.1 Weight gain is common in children on vigabatrin.2 In trials of people aged 10 to 64, mood changes such as depression were reported more often than with placebo.3 The most serious risk at every age is permanent loss of side vision, which is why vigabatrin carries a boxed warning.2
Sabril, Vigafyde, Vigadrone and other generic versions all contain the same medicine. Vigadrone is a generic powder approved through an abbreviated application, so what this page says applies to it too.4,5
- Vigabatrin
- Comparison group
Brain MRI changes in infants with spasms
Weight gain of 7% or more (pooled pediatric trials)
Show as a table
| Group | Measure | Value |
|---|---|---|
| Brain MRI changes in infants with spasms | Vigabatrin | 22% |
| Brain MRI changes in infants with spasms | Other treatments | 4% |
| Weight gain of 7% or more (pooled pediatric trials) | Vigabatrin | 47% |
| Weight gain of 7% or more (pooled pediatric trials) | Placebo | 19% |
Vigabatrin side effects in babies
In babies, vigabatrin is approved for infantile spasms.7 A Cochrane review says it may be the treatment of choice when the spasms are caused by tuberous sclerosis complex.8 A review of non-vision side effects found that sedation, sleepiness and irritability are common in infants.1 Practical advice: if your baby seems unusually sleepy or is feeding less well, tell the prescriber, and do not change the dose or timing on your own.
Changes on brain MRI scans
Some babies on vigabatrin show new signal changes on brain MRI scans. Some of these babies have no symptoms from them, and some do.9 In one study of 108 babies on vigabatrin, 17 had these changes, and 11 of those 17 had symptoms.10
- How common. In a study of 205 babies with infantile spasms, MRI changes were seen in 22% of those on vigabatrin and 4% of those on other treatments. The FDA labels quote these figures.2,6 The same study found no extra MRI changes in children or adults treated for refractory complex partial seizures.6
- Who is affected. In other studies, affected babies tended to be younger, often under 12 months, and on higher doses.11,12
- Do they go away? In the studies that followed babies up, the changes usually went away after vigabatrin was stopped. In the 205-baby study they cleared in 6 of the 9 babies with a follow-up scan.6,11,12
What affects the risk is debated. One study linked the symptom-free MRI changes to the highest daily dose a baby reached, and its authors advised caution above 175 mg/kg/day. That study also found a small number of babies with symptoms from the changes, possibly linked to taking hormone treatment at the same time.9 A 2025 study found that babies with symptoms were more likely to be on hormone treatment as well, but did not find a link with peak dose.10 If your baby is on both vigabatrin and a hormone treatment such as steroids or ACTH, ask the neurologist how they plan to watch for this. Summaries of these and other studies are on the vigabatrin research page.
The same review of non-vision side effects also discusses the history of intramyelinic edema, a type of swelling within the brain's white matter.1
Side effects in children and adults
Drowsiness, dizziness and fatigue
In adults, the most common side effects are drowsiness, dizziness, headache and fatigue.1 A Cochrane review of 11 add-on trials found that people on vigabatrin had more dizziness, fatigue and drowsiness than people on placebo, and were nearly three times as likely to stop treatment early.3 In pooled pediatric trials, sleepiness was reported in 6% on vigabatrin vs 5% on placebo, and fatigue in 10% vs 7%.2
Weight gain
Weight gain is one of the clearer differences from placebo. In pooled pediatric trials, 47% of children on vigabatrin gained 7% or more of their body weight, against 19% on placebo.2 In a trial in people with newly diagnosed epilepsy, weight gain was reported in 11% on vigabatrin and 5% on carbamazepine.13
Mood and behavior
Depression was reported more often with vigabatrin than with placebo in the Cochrane review, and psychosis has also been reported more often than with placebo.1,3 In the trial against carbamazepine, psychiatric symptoms were reported in 25% on vigabatrin vs 15% on carbamazepine.13 The labels also carry a warning, shared by all seizure medicines, that these drugs increase the risk of suicidal thoughts or behavior.2,7 Tell the prescriber about new or worsening low mood, agitation or unusual behavior. If someone talks about harming themselves, call or text the 988 Suicide & Crisis Lifeline in the US, which is free and open 24/7, or call emergency services.14
The Cochrane results come from people aged 10 to 64, and the authors say they should not be applied to children under 10.3
Vision loss
Vigabatrin can cause permanent loss of side vision in both eyes, and it can also reduce sharpness of vision. The risk rises with dose and with total time on the medicine, and no dose is known to be free of risk.2 Based on adult studies, the label says 30% or more of patients can be affected.7 Everyone on vigabatrin has regular vision checks through the REMS program.
Stopping vigabatrin suddenly
The label says not to stop vigabatrin suddenly; it should be withdrawn gradually to avoid more seizures.2,7 In the infantile spasms study, the dose was lowered by 25 to 50 mg/kg every 3 to 4 days.2 The prescriber sets the plan.
Seizure types vigabatrin can worsen
The Medication Guide warns that vigabatrin "may make certain types of seizures worse," both in babies with infantile spasms and in people with complex partial seizures. It asks families to tell the prescriber right away if seizures get worse. The US label does not say which seizure types.7
The medical literature points mainly to absence and myoclonic seizures:
- Absence seizures (brief staring spells). A review of seizure medicines that make epilepsy worse says typical absence seizures in idiopathic generalized epilepsies are consistently increased by vigabatrin, as they are by carbamazepine, tiagabine and gabapentin.15
- Myoclonic seizures (sudden jerks). The same review says that in symptomatic generalized epilepsies, myoclonic jerks are generally made worse by the same drugs.15
- New absence seizures. A case series described three patients who developed absence seizures for the first time after carbamazepine and vigabatrin. The seizures settled quickly once the drugs were stopped. The authors advise thinking of the medicine whenever seizures increase or a new seizure type appears after a treatment change.16
If you notice new staring spells, new jerks or more seizures after vigabatrin is started or raised, tell the prescriber promptly. Do not stop it suddenly; the label says it should be withdrawn gradually.7
Vigabatrin overdose: symptoms and what to do
If you think your child or anyone else has taken too much vigabatrin, call Poison Help at 1-800-222-1222 in the US right away.17 Practical advice: call emergency services if the person is very hard to wake, has trouble breathing or has a seizure, and keep the bottle or packet with you when you call.
Overdose symptoms
The label describes overdoses reported in clinical trials and after approval. None of them caused death. The amounts taken ranged from 3 g to 90 g, most between 7.5 g and 30 g, and nearly half of the cases also involved other medicines.7
- Most common: drowsiness, unconsciousness or coma.
- Less common: slowed or stopped breathing (respiratory depression or apnea), a slow heart rate, low blood pressure, vertigo, headache, agitation, irritability, confusion, abnormal behavior, psychosis, speech problems, more seizures, and status epilepticus (a seizure that does not stop).7
These symptoms went away with supportive care.7
How an overdose is managed
There is no specific antidote. The label advises standard measures to remove drug not yet absorbed, plus supportive care, including monitoring of vital signs. In a lab study, activated charcoal did not bind vigabatrin to any significant degree. Whether hemodialysis helps in an overdose is unknown. In isolated reports of patients with kidney failure on normal doses, hemodialysis lowered vigabatrin blood levels by 40% to 60%. The Vigafyde label carries the same overdose information.7
Preventing dosing mistakes
The label says to measure each dose with a calibrated device such as the oral syringe from the pharmacy, not a household spoon.2 As practical advice, also keep the dose in mL in writing. When babies switch between forms, the volume changes even though the dose in mg does not.
When to call the prescriber
- Your baby is too sleepy to feed well, or is much more irritable than usual.
- Your child seems to bump into things, misses objects at the side, or does not follow faces or toys as before.
- You notice low mood, agitation or other behavior changes.
- Seizures or spasms come back or get worse.
- You have missed doses or think a dose was wrong.
Common questions
What are the most common side effects of vigabatrin in babies?
Sleepiness, sedation and irritability are the side effects most often seen in babies. Some babies also show changes on brain MRI scans, which in most reported cases went away after vigabatrin was stopped. The most serious risk at any age is permanent loss of side vision.
Does vigabatrin cause weight gain?
It can. In pooled pediatric trials, 47% of children on vigabatrin gained 7% or more of their body weight, compared with 19% on placebo. In a trial in people with newly diagnosed epilepsy, weight gain was reported in 11% on vigabatrin and 5% on carbamazepine.
Are Vigadrone side effects different from Sabril side effects?
No. Vigadrone is a generic vigabatrin powder. It contains the same medicine as Sabril and Vigafyde, so it carries the same side effects and the same vision-loss warning.
Can vigabatrin cause depression?
In trials in adults and older children, depression was reported more often with vigabatrin than with placebo. Tell the prescriber about any new or worsening low mood, behavior change or unusual thoughts.
What should I do if my child gets too much vigabatrin?
Call Poison Help at 1-800-222-1222 in the US. Practical advice: call emergency services if your child is very hard to wake, has trouble breathing or has a seizure, and have the bottle or packet with you when you call.
What are the symptoms of a vigabatrin overdose?
In the overdoses described in the label, drowsiness, unconsciousness or coma were the most common. Less common were slowed or stopped breathing, a slow heart rate, low blood pressure, agitation, confusion and more seizures. There is no specific antidote. The symptoms went away with supportive care, and none of the reported overdoses caused death.
Can vigabatrin make some seizures worse?
Yes. The Medication Guide says vigabatrin may make certain types of seizures worse. The medical literature points mainly to absence seizures (staring spells) and myoclonic seizures (sudden jerks). Tell the prescriber right away if seizures increase or a new type appears, and do not stop vigabatrin suddenly.
References
- 1.Walker SD, Kälviäinen R. Non-vision adverse events with vigabatrin therapy. Acta Neurol Scand Suppl. 2011;(192):72-82. PMID 22061182 · DOI 10.1111/j.1600-0404.2011.01602.x PubMedDOI
- 2.VIGAFYDE (vigabatrin) oral solution prescribing information, revised 11/2025. Source
- 3.Bresnahan R, Gianatsi M, Maguire MJ, et al. Vigabatrin add-on therapy for drug-resistant focal epilepsy. Cochrane Database Syst Rev. 2020;7(7):CD007302. PMID 32730657 · DOI 10.1002/14651858.CD007302.pub3 PubMedDOI
- 4.Drugs@FDA (openFDA): numerous ANDAs for vigabatrin for oral solution 500 mg/packet and tablets 500 mg. Examples: VIGADRONE ANDA 210196 (approved 2018-06-21; DailyMed labeler now Upsher-Smith); VIGPODER ANDA 214961 (Pyros; openFDA product: vigabatrin 500MG/PACKET, dosage form "FOR SOLUTION", route oral, TE code AA, i.e. a powder for oral solution; original approval 2022-06-24; no current DailyMed SPL found under the name Vigpoder); Teva, Amneal, Dr. Reddy's, Zydus and others. VIGAFYDE was the only vigabatrin "SOLUTION" (ready-to-use) dosage form in the results. Source
- 5.VIGADRONE (vigabatrin) for oral solution, revised 12/2025, Upsher-Smith. Source
- 6.Wheless JW, Carmant L, Bebin M, et al. Magnetic resonance imaging abnormalities associated with vigabatrin in patients with epilepsy. Epilepsia. 2009;50(2):195-205. PMID 19054414 · DOI 10.1111/j.1528-1167.2008.01896.x PubMedDOI
- 7.SABRIL (vigabatrin) tablets prescribing information, revised 10/2021. Source
- 8.Hancock EC, Osborne JP, Edwards SW. Treatment of infantile spasms. Cochrane Database Syst Rev. 2013;(6):CD001770. PMID 23740534 · DOI 10.1002/14651858.CD001770.pub3 PubMedDOI
- 9.Hussain SA, Tsao J, Li M, et al. Risk of vigabatrin-associated brain abnormalities on MRI in the treatment of infantile spasms is dose-dependent. Epilepsia. 2017;58(4):674-682. PMID 28230253 · DOI 10.1111/epi.13712 PubMedDOI
- 10.Sathe R, Shrestha G, Terango A, et al. Symptomatic vigabatrin-associated MRI toxicity is associated with simultaneous hormonal therapy among patients with infantile spasms. Epilepsia Open. 2025;10(1):314-320. PMID 39570186 · DOI 10.1002/epi4.13099 PubMedDOI
- 11.Pearl PL, Vezina LG, Saneto RP, et al. Cerebral MRI abnormalities associated with vigabatrin therapy. Epilepsia. 2009;50(2):184-194. PMID 18783433 · DOI 10.1111/j.1528-1167.2008.01728.x PubMedDOI
- 12.Dracopoulos A, Widjaja E, Raybaud C, et al. Vigabatrin-associated reversible MRI signal changes in patients with infantile spasms. Epilepsia. 2010;51(7):1297-1304. PMID 20384718 · DOI 10.1111/j.1528-1167.2010.02564.x PubMedDOI
- 13.Chadwick D. Safety and efficacy of vigabatrin and carbamazepine in newly diagnosed epilepsy: a multicentre randomised double-blind study. Lancet. 1999;354(9172):13-19. PMID 10406359 · DOI 10.1016/s0140-6736(98)10531-710531-7) PubMedDOI
- 14.988 Suicide & Crisis Lifeline. SAMHSA, · Lifeline site Source
- 15.Genton P. When antiepileptic drugs aggravate epilepsy. Brain Dev. 2000;22(2):75-80. PMID 10722956 · DOI 10.1016/s0387-7604(99)00113-800113-8) PubMedDOI
- 16.Yang MT, Lee WT, Chu LW, et al. Anti-epileptic drugs-induced de novo absence seizures. Brain Dev. 2003;25(1):51-56. PMID 12536034 · DOI 10.1016/s0387-7604(02)00120-100120-1) PubMedDOI
- 17.Poison Help line, 1-800-222-1222. MedlinePlus (National Library of Medicine), Poisoning: · HRSA Poison Help: Source